These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31977281)

  • 1. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.
    Sun X; Tang F; Hu Y; Deng X; Wang Z; Zhou M; Liu Y
    Hum Vaccin Immunother; 2020 Jul; 16(7):1738-1742. PubMed ID: 31977281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine.
    Liu Y; Hu Y; Deng X; Wang Z; Lu P; Ma F; Zhou M; Liu P; Min J
    Sci Rep; 2015 Oct; 5():14660. PubMed ID: 26423223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a mixture model to assess the effect of measles-mumps-rubella vaccine on the mumps epidemic in children from kindergarten to early school age in Jiangsu Province, China.
    Zhang L; Wang Z; Hu Y; Deng X; Guo H; Sun X; Tang F; Zhou M; Liu Y
    Hum Vaccin Immunother; 2018; 14(11):2654-2659. PubMed ID: 29792546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
    Liu Y; Xiong Y; Liang Y; Deng X; Hu Y; Hu R; Chen Q; Tang F; Wang Z; Sun X; Guo H; Zhang L; Zhu FC
    Vaccine; 2021 Jun; 39(26):3509-3515. PubMed ID: 33994238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of mumps immunity after administrating measles-mumps-rubella vaccine among children aged 2-7 years old in Jiangsu Province in 2015].
    Liu YB; Hu Y; Deng XY; Wang ZG; Sun X; Lu PS; Guo HX; Tang FY; Zhou MH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):593-597. PubMed ID: 28693082
    [No Abstract]   [Full Text] [Related]  

  • 6. Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study.
    Liu Y; Liu Z; Deng X; Hu Y; Wang Z; Lu P; Guo H; Sun X; Xu Y; Tang F; Zhu FC
    Expert Rev Vaccines; 2018 May; 17(5):445-452. PubMed ID: 29478347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
    PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China.
    Li D; Zhang H; You N; Chen Z; Yang X; Zhang H; Zhou Y; Zheng N; Pan W
    Hum Vaccin Immunother; 2022 Nov; 18(6):2096375. PubMed ID: 35950847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
    Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
    Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
    Pang H; Zhou Y; Zhao W; Jiang Q
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30249033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A; Masunu-Faleafaga Y; Walls L; Williams N; Garcia P; Teshale E; Williams R; Dulski T; Bellini WJ; Kutty PK
    Vaccine; 2013 Aug; 31(36):3683-7. PubMed ID: 23770334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
    Angsuwatcharakon P; Puthanakit T; Bunjoungmanee P; Anugulruengkitt S; Srimuan P; Kowitdamrong E; Savangsindh P; Sophonphan J; Tantawichien T; Tangsathapornpong A
    Vaccine; 2021 Oct; 39(42):6206-6209. PubMed ID: 34556367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C; Mankertz A
    PLoS One; 2012; 7(8):e42867. PubMed ID: 22880124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.